Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. This means it acts on both the GLP-1 and GIP receptors to enhance the body’s response to glucose and improve blood sugar control. Tirzepatide helps to lower blood sugar levels, reduce appetite, and promote weight loss. This makes it a valuable treatment option for people with type 2 diabetes who struggle with obesity, as it can help improve both blood sugar control and weight management.